IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis

Malcolm R. Starkey, Maximilian W. Plank, Paolo Casolari, Alberto Papi, Stelios Pavlidis, Yike Guo, Guy J.M. Cameron, Tatt Jhong Haw, Anthony Tam, Ma'en Obiedat, Chantal Donovan, Nicole G. Hansbro, Duc H. Nguyen, Prema Mono Nair, Richard Y. Kim, Jay C. Horvat, Gerard E. Kaiko, Scott K. Durum, Peter A. Wark, Don D. Sin, Gaetano Caramori, Ian M. Adcock, Paul S. Foster, Philip M. Hansbro

Source: Eur Respir J, 54 (1) 1800174; 10.1183/13993003.00174-2018
Journal Issue: July
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Malcolm R. Starkey, Maximilian W. Plank, Paolo Casolari, Alberto Papi, Stelios Pavlidis, Yike Guo, Guy J.M. Cameron, Tatt Jhong Haw, Anthony Tam, Ma'en Obiedat, Chantal Donovan, Nicole G. Hansbro, Duc H. Nguyen, Prema Mono Nair, Richard Y. Kim, Jay C. Horvat, Gerard E. Kaiko, Scott K. Durum, Peter A. Wark, Don D. Sin, Gaetano Caramori, Ian M. Adcock, Paul S. Foster, Philip M. Hansbro. IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis. Eur Respir J, 54 (1) 1800174; 10.1183/13993003.00174-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The roles of Th2 cytokines and their signaling pathways in the pathogenesis of non-eosinophilic asthma enhanced by dsRNA
Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs
Year: 2006


The involvement of thrombospondin-1 in COPD pathogenesis through IL-8 production
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013

A decreased expression of leptin receptor may contribute to the pathogenesis of the allergic rhinitis
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010

The role of lipoxin A4 and its receptor in pathogenesis of inflammatory lung diseases
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010


IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation.
Source: International Congress 2018 – Novel drug targets for asthma and COPD
Year: 2018



Anti-Th2 cytokines inhibit progression in a murine model of childhood asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010


IL-33 may augment the effect of rhinovirus HRV16 on the inflammatory activity of human lung vascular endothelium – possible implication for asthma exacerbations.
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021

PAH and inflammation: its role in pathogenesis - is it of value to modulate it?
Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension
Year: 2005

The role of IL-10 receptors in aberrant homeostatic control of TNF-α in idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2002; 20: Suppl. 38, 599s
Year: 2002

GM-CSF is a key pathogenic mediator in experimental COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 13s
Year: 2005

Human rhinovirus 16 infection of human macrophages significantly impairs their phagocytic and regulatory functions: implications in understanding chronic inflammatory lung disease
Source: International Congress 2017 – New Mechanistic Findings in COPD
Year: 2017



Evidence for differential roles of Th1 and Th17 cytokines in the pathogenesis of COPD
Source: Annual Congress 2010 - Pathology and immunology of COPD
Year: 2010



Carbocisteine in vivo reduces circulating miR-21 and IL-8 in exacerbated COPD patients
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019

The role of the COPD susceptibility gene FAM13A in barrier function and pro-inflammatory responses of human airway epithelial cells
Source: ERS Lung Science Conference 2020
Year: 2020

IL-33 augments rhinovirus-induced type 2 immune responses in asthma via selective upregulation of one chain of the IL-33 receptor.
Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Year: 2017


IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016

RAGE-dependent VCAM-1 expression in the pulmonary endothelium mediates IL-33 induced asthma pathogenesis
Source: International Congress 2017 – Therapeutic approaches in lung disease
Year: 2017


Transgenic mice overexpressing IL-18 display increased IL-13 in the airways but no changes of the airway hyperresponsiveness in a murine model of late-phase asthma: evidence for a dual role of IL-18 on mucosal Th1/Th2 responses
Source: Eur Respir J 2002; 20: Suppl. 38, 1s
Year: 2002

Th17 cytokines: novel potential therapeutic targets for COPD pathogenesis and exacerbations
Source: Eur Respir J, 50 (4) 1602434; 10.1183/13993003.02434-2016
Year: 2017



Interferon-gamma (IFN-γ) alters the expression of IP-10 and IL-18 in human aveolar epithelial cells type II. Possible role in the reinforcement of Th1-dominated lung inflammation
Source: Eur Respir J 2001; 18: Suppl. 33, 521s
Year: 2001